BriaCell Therapeutics Corp.
BCTX
$3.65
-$0.01-0.27%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
2/14/2025
-
MarketBeat
3/12/2025
-
TipRanks Financial Blog
2/13/2025
-
Ticker Report
2/6/2025
-
GuruFocus
2/5/2025
-
Globe Newswire
2/5/2025
-
GuruFocus
2/5/2025
-
Globe Newswire
2/5/2025
-
Ticker Report
2/4/2025
-
SeekingAlpha.com: All News
2/4/2025
-
Seeking Alpha - Healthcare
2/4/2025
-
TipRanks Financial Blog
2/4/2025
-
GuruFocus
2/4/2025
-
Globe Newswire
2/3/2025
-
TipRanks Financial Blog
2/3/2025
-
GuruFocus
2/3/2025
-
Seeking Alpha - Healthcare
2/3/2025
-
Globe Newswire
2/3/2025
-
The Fly
2/3/2025
-
The Fly
2/3/2025
-
Globe Newswire
1/29/2025
-
The Fly
1/27/2025
-
Globe Newswire
1/13/2025
-
Ticker Report
1/3/2025
-
TipRanks Financial Blog
1/3/2025
-
Globe Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, December 16, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Mar 17 and 21 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
604-921-1810
Address
Bellevue Centre
Suite 300 - 235 -15th Street
West Vancouver, BC V7T 2X1
Suite 300 - 235 -15th Street
West Vancouver, BC V7T 2X1
Country
Year Founded
--
Business Description
Sector
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted...
more
